Loomis C W, Milne B, Cervenko F W
Department of Anaesthesia, Faculty of Medicine, Queen's University, Kingston, Canada.
Neuropharmacology. 1988 Feb;27(2):191-9. doi: 10.1016/0028-3908(88)90170-0.
In the rat, the continuous intrathecal (i.t.) infusion of clonidine (0.4 microgram/hr) significantly increased the tail-flick latency (TF) and the threshold for paw pressure (PP) withdrawal for 5 days and decreased the systolic blood pressure (up to 24 mm Hg) for 7 days. The antinociceptive effect of continuous intrathecal infusion of clonidine (0.4 microgram/hr) in the tail flick and paw pressure tests was not attenuated in rats that were tolerant to morphine. The acute intrathecal administration of clonidine (2.7 micrograms) and morphine (1.0 microgram) resulted in a synergistic interaction in the tail-flick and paw pressure tests. A synergistic interaction was also observed during the continuous intrathecal infusion of morphine (1.25 micrograms/hr) and clonidine (0.2 microgram/hr) in the tail-flick and paw pressure tests. Individually, these doses of morphine and clonidine had no antinociceptive effect. However, intrathecal infusion together yielded peak tail-flick and paw pressure responses comparable to that of 0.4 microgram/hr clonidine alone, without affecting systolic blood pressure. No delay in the onset of tolerance to the analgesic effect was observed with the combination as compared with clonidine (0.4 microgram/hr) alone. The data indicate that clonidine-induced spinal analgesia is independent of endogenous opioid systems linked to mu-receptors in the spinal cord, and that optimization of spinal analgesia (e.g. synergism) can be achieved during continuous intrathecal infusion without affecting cardiovascular activity.
在大鼠中,持续鞘内注射可乐定(0.4微克/小时)可使甩尾潜伏期(TF)和爪部压力撤离阈值(PP)显著增加5天,并使收缩压降低(最多24毫米汞柱)7天。在对吗啡耐受的大鼠中,持续鞘内注射可乐定(0.4微克/小时)在甩尾和爪部压力测试中的抗伤害感受作用并未减弱。急性鞘内注射可乐定(2.7微克)和吗啡(1.0微克)在甩尾和爪部压力测试中产生协同作用。在持续鞘内注射吗啡(1.25微克/小时)和可乐定(0.2微克/小时)的甩尾和爪部压力测试中也观察到协同作用。单独使用时,这些剂量的吗啡和可乐定均无抗伤害感受作用。然而,鞘内联合注射产生的甩尾和爪部压力峰值反应与单独使用0.4微克/小时可乐定的反应相当,且不影响收缩压。与单独使用可乐定(0.4微克/小时)相比,联合用药未观察到镇痛作用耐受性出现延迟。数据表明,可乐定诱导的脊髓镇痛独立于与脊髓中μ受体相关的内源性阿片系统,并且在持续鞘内注射期间可实现脊髓镇痛的优化(如协同作用),而不影响心血管活动。